Suppr超能文献

从处方药转换为非处方药:消费者及管理式医疗视角

Switching from prescription to over-the counter medications: a consumer and managed care perspective.

作者信息

Pawaskar Manjiri D, Balkrishnan Rajesh

机构信息

Department of Pharmacy Practice and Administration, College of Pharmacy, Ohio State University, Columbus, OH 43210, USA.

出版信息

Manag Care Interface. 2007 Jan;20(1):42-7.

Abstract

An extensive literature review using databases, such as MEDLINE, Cochrane Collaboration, and ScienceDirect, provided information on the current trends, benefits, risks, and effects of switched medications on consumers MCOs. More than 80 ingredients or 700 medications have been changed from prescription (Rx) to over-the-counter (OTC) status. Although the Rx-to-OTC switch has resulted in significant cost savings for consumers (13 billion dollars) and MCOs (20 million dollars), the misuse of medications can cause side effects, hospitalizations, and even death. In conclusion, a balance must be struck between the increasing demand for these switched medications and their safety risks. In addition, the long-term benefits of many of these medications are still uncertain and need further exploration.

摘要

通过使用如MEDLINE、Cochrane协作网和ScienceDirect等数据库进行的广泛文献综述,提供了有关转换药物对消费者和医疗保健机构(MCOs)的当前趋势、益处、风险及影响的信息。超过80种成分或700种药物已从处方药(Rx)转为非处方药(OTC)状态。尽管从处方药转换为非处方药已为消费者节省了大量成本(130亿美元),为医疗保健机构节省了2000万美元,但药物的误用可能会导致副作用、住院甚至死亡。总之,必须在对这些转换药物不断增长的需求与其安全风险之间取得平衡。此外,许多此类药物的长期益处仍不确定,需要进一步探索。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验